India Women’s Health Therapeutics MarketIndia Women’s Health Therapeutics Market Decade Long Trends, Analysis and Forecast 2024-2032
India Women’s Health Therapeutics Market by Application (Contraceptive Drugs, Dysmenorrhea Therapeutics, Antibiotics, Antifungals, Hormone Replacement, Acne Treatment, Bone Health, Others), by Forecast 2024-2032
Base Year: 2023
180 Pages
India Women’s Health Therapeutics Market Decade Long Trends, Analysis and Forecast 2024-2032
Key Insights
The India Women’s Health Therapeutics Market size was valued at USD 1.98 USD billion in 2023 and is projected to reach USD 6.12 USD billion by 2032, exhibiting a CAGR of 17.5 % during the forecast period. Women’s health therapeutics can be described as a branch of medicine and treatment that targets and treats all aspects of women’s health. Such medicines include contraceptives, hormone replacement therapies, drugs, and surgery concerning pregnancy, menstruation, fertility, post-menopausal symptoms, thinning of bones, breast cancer, and other diseases of the ladies’ reproductive system. Key highlights include the hormone replacement, contraceptives, fertility medications, and management of menstrual complications. It applies for symptom control during the menopausal period but also for fertility treatment and in conditions such as endometriosis and PCOS. The advantages of these therapeutics are immense as they relieve illnesses, improve the quality of people’s lives, and manage diseases. Further, this particular field is significant in the early diagnosis and, therefore, the improved prognosis of gynaecological malignancies.
India Women’s Health Therapeutics Trends
- Increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases among women
- Growing demand for minimally invasive and non-invasive surgical procedures
- Rising awareness about the importance of preventive healthcare
- Increasing use of telemedicine and online healthcare services
Driving Forces: What's Propelling the India Women’s Health Therapeutics Market
- Growing awareness about women's health issues
- Rising disposable income
- Government initiatives to improve women's health
- Increasing prevalence of chronic diseases among women
- Growing demand for minimally invasive and non-invasive surgical procedures
Challenges and Restraints in India Women’s Health Therapeutics Market
- Lack of access to quality healthcare services in rural areas
- High cost of treatment
- Cultural barriers to seeking healthcare
- Low level of health literacy among women
- Shortage of qualified healthcare professionals
Emerging Trends in India Women’s Health Therapeutics
- Telemedicine and online healthcare services
- Personalized medicine
- Artificial intelligence and machine learning
- Big data and analytics
Growth Catalysts in India Women’s Health Therapeutics Industry
- Government initiatives to improve women's health
- Public-private partnerships to provide affordable healthcare services
- Increasing awareness about women's health issues
- Growing demand for preventive healthcare
Market Segmentation: India Women’s Health Therapeutics Analysis
Application:
- Hormonal Drugs
- Contraception and Fertility Drugs
- Therapeutics for menstrual disorders
- Urinary Tract Infection drugs
End-users:
- Hospitals
- Clinics
- Pharmacies
- Online platforms
Leading Players in the India Women’s Health Therapeutics Market
- Sun Pharmaceutical Industries Ltd. (India)
- Dr. Reddy’s Laboratories Ltd. (India)
- Cipla Inc. (India)
- Abbott (U.S.)
- Lupin (India)
- Bayer AG (Germany)
- Torrent Pharmaceuticals Ltd. (India)
- Glenmark Pharmaceuticals Limited (India)
- Granules India Limited (India)
- Emami Limited (India)
Significant Developments in India's Women’s Health Therapeutics Sector
- In 2022, the Government of India launched the National Health Mission (NHM), which aims to provide comprehensive healthcare services to women.
- In 2021, the Indian Council of Medical Research (ICMR) launched a new program to study the prevalence of cervical cancer in India.
- In 2020, the World Health Organization (WHO) launched a new initiative to improve maternal health in India.
Comprehensive Coverage India Women’s Health Therapeutics Market Report
- Market size and growth rate
- Analysis of key market segments
- Profiles of leading market players
- Industry trends and developments
- Regional market analysis
- Analysis of market opportunities, drivers, and challenges
Regional Insight
- North India
- South India
- East India
- West India
DROCT
- D: Drivers
- Increasing awareness about women's health issues
- Rising disposable income
- Government initiatives to improve women's health
- R: Restraints
- Lack of access to quality healthcare services in rural areas
- High cost of treatment
- Cultural barriers to seeking healthcare
- O: Opportunities
- Telemedicine and online healthcare services
- Personalized medicine
- Artificial intelligence and machine learning
- C: Challenges
- Low level of health literacy among women
- Shortage of qualified healthcare professionals
Pricing Analysis
- Factors influencing pricing
- Pricing strategies
- Competitive analysis
Import And Export Analysis
- Import and export trends
- Major importing countries
- Major exporting countries
Segmentation
- Segmentation by application
- Segmentation by end-users
Patent/Trademark Analysis
- Key patents and trademarks
- Analysis of patent and trademark filings
India Women’s Health Therapeutics Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2018-2032 |
| Base Year | 2023 |
| Estimated Year | 2024 |
| Forecast Period | 2024-2032 |
| Historical Period | 2018-2023 |
| Growth Rate | CAGR of 17.5% from 2018-2032 |
| Segmentation |
|
Frequently Asked Questions
Table Of Content
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rising Strategic Collaborations among Key Market Players to Propel Market Growth
- 3.3. Market Restrains
- 3.3.1. Availability of Alternate Treatment Options to Limit the Adoption Rate of Women’s Health Therapeutics
- 3.4. Market Trends
- 3.4.1. Increasing Number of Hospitals and ASCs Identified as Significant Market Trend
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. India Women’s Health Therapeutics Market Analysis, Insights and Forecast, 2018-2030
- 5.1. Market Analysis, Insights and Forecast - by Application
- 5.1.1. Contraceptive Drugs
- 5.1.2. Dysmenorrhea Therapeutics
- 5.1.3. Antibiotics
- 5.1.4. Antifungals
- 5.1.5. Hormone Replacement
- 5.1.6. Acne Treatment
- 5.1.7. Bone Health
- 5.1.8. Others
- 5.2. Market Analysis, Insights and Forecast - by Region
- 5.2.1.
- 5.1. Market Analysis, Insights and Forecast - by Application
- 6. North India India Women’s Health Therapeutics Market Analysis, Insights and Forecast, 2018-2030
- 6.1. Market Analysis, Insights and Forecast - By Application
- 6.1.1 Contraceptive Drugs
- 6.1.2 Dysmenorrhea Therapeutics
- 6.1.3 Antibiotics
- 6.1.4 Antifungals
- 6.1.5 Hormone Replacement
- 6.1.6 Acne Treatment
- 6.1.7 Bone Health
- 6.1.8 and Others
- 7. South India India Women’s Health Therapeutics Market Analysis, Insights and Forecast, 2018-2030
- 7.1. Market Analysis, Insights and Forecast - By Application
- 7.1.1 Contraceptive Drugs
- 7.1.2 Dysmenorrhea Therapeutics
- 7.1.3 Antibiotics
- 7.1.4 Antifungals
- 7.1.5 Hormone Replacement
- 7.1.6 Acne Treatment
- 7.1.7 Bone Health
- 7.1.8 and Others
- 8. East India India Women’s Health Therapeutics Market Analysis, Insights and Forecast, 2018-2030
- 8.1. Market Analysis, Insights and Forecast - By Application
- 8.1.1 Contraceptive Drugs
- 8.1.2 Dysmenorrhea Therapeutics
- 8.1.3 Antibiotics
- 8.1.4 Antifungals
- 8.1.5 Hormone Replacement
- 8.1.6 Acne Treatment
- 8.1.7 Bone Health
- 8.1.8 and Others
- 9. West India India Women’s Health Therapeutics Market Analysis, Insights and Forecast, 2018-2030
- 9.1. Market Analysis, Insights and Forecast - By Application
- 9.1.1 Contraceptive Drugs
- 9.1.2 Dysmenorrhea Therapeutics
- 9.1.3 Antibiotics
- 9.1.4 Antifungals
- 9.1.5 Hormone Replacement
- 9.1.6 Acne Treatment
- 9.1.7 Bone Health
- 9.1.8 and Others
- 10. Competitive Analysis
- 10.1. Market Share Analysis 2023
- 10.2. Company Profiles
- 10.2.1 Sun Pharmaceutical Industries Ltd. (India)
- 10.2.1.1. Overview
- 10.2.1.2. Products
- 10.2.1.3. SWOT Analysis
- 10.2.1.4. Recent Developments
- 10.2.1.5. Financials (Based on Availability)
- 10.2.2 Dr. Reddy’s Laboratories Ltd. (India)
- 10.2.2.1. Overview
- 10.2.2.2. Products
- 10.2.2.3. SWOT Analysis
- 10.2.2.4. Recent Developments
- 10.2.2.5. Financials (Based on Availability)
- 10.2.3 Cipla Inc. (India)
- 10.2.3.1. Overview
- 10.2.3.2. Products
- 10.2.3.3. SWOT Analysis
- 10.2.3.4. Recent Developments
- 10.2.3.5. Financials (Based on Availability)
- 10.2.4 Abbott (U.S.)
- 10.2.4.1. Overview
- 10.2.4.2. Products
- 10.2.4.3. SWOT Analysis
- 10.2.4.4. Recent Developments
- 10.2.4.5. Financials (Based on Availability)
- 10.2.5 Lupin (India)
- 10.2.5.1. Overview
- 10.2.5.2. Products
- 10.2.5.3. SWOT Analysis
- 10.2.5.4. Recent Developments
- 10.2.5.5. Financials (Based on Availability)
- 10.2.6 Bayer AG (Germany)
- 10.2.6.1. Overview
- 10.2.6.2. Products
- 10.2.6.3. SWOT Analysis
- 10.2.6.4. Recent Developments
- 10.2.6.5. Financials (Based on Availability)
- 10.2.7 Torrent Pharmaceuticals Ltd. (India)
- 10.2.7.1. Overview
- 10.2.7.2. Products
- 10.2.7.3. SWOT Analysis
- 10.2.7.4. Recent Developments
- 10.2.7.5. Financials (Based on Availability)
- 10.2.8 Glenmark Pharmaceuticals Limited (India)
- 10.2.8.1. Overview
- 10.2.8.2. Products
- 10.2.8.3. SWOT Analysis
- 10.2.8.4. Recent Developments
- 10.2.8.5. Financials (Based on Availability)
- 10.2.9 Granules India Limited (India)
- 10.2.9.1. Overview
- 10.2.9.2. Products
- 10.2.9.3. SWOT Analysis
- 10.2.9.4. Recent Developments
- 10.2.9.5. Financials (Based on Availability)
- 10.2.10 Emami Limited (India)
- 10.2.10.1. Overview
- 10.2.10.2. Products
- 10.2.10.3. SWOT Analysis
- 10.2.10.4. Recent Developments
- 10.2.10.5. Financials (Based on Availability)
- 10.2.1 Sun Pharmaceutical Industries Ltd. (India)
List of Figures
- Figure 1: India Women’s Health Therapeutics Market Revenue Breakdown (USD billion, %) by Product 2023 & 2031
- Figure 2: India Women’s Health Therapeutics Market Value Share (%), by Application 2023 & 2031
- Figure 3: India Women’s Health Therapeutics Market Share (%) by Company 2023
List of Tables
- Table 1: India Women’s Health Therapeutics Market Revenue USD billion Forecast, by Application 2018 & 2031
- Table 2: India Women’s Health Therapeutics Market Volume 1,000 Units Forecast, by Application 2018 & 2031
- Table 3: India Women’s Health Therapeutics Market Revenue USD billion Forecast, by Region 2018 & 2031
- Table 4: India Women’s Health Therapeutics Market Volume 1,000 Units Forecast, by Region 2018 & 2031
- Table 5: India Women’s Health Therapeutics Market Revenue USD billion Forecast, by Application 2018 & 2031
- Table 6: India Women’s Health Therapeutics Market Volume 1,000 Units Forecast, by Application 2018 & 2031
- Table 7: India Women’s Health Therapeutics Market Revenue USD billion Forecast, by Region 2018 & 2031
- Table 8: India Women’s Health Therapeutics Market Volume 1,000 Units Forecast, by Region 2018 & 2031
- Table 9: India Women’s Health Therapeutics Market Revenue USD billion Forecast, by Application 2018 & 2031
- Table 10: India Women’s Health Therapeutics Market Volume 1,000 Units Forecast, by Application 2018 & 2031
- Table 11: India Women’s Health Therapeutics Market Revenue USD billion Forecast, by Country 2018 & 2031
- Table 12: India Women’s Health Therapeutics Market Volume 1,000 Units Forecast, by Country 2018 & 2031
- Table 13: North India India Women’s Health Therapeutics Market Revenue (USD billion) Forecast, by Application 2018 & 2031
- Table 14: North India India Women’s Health Therapeutics Market Volume (1,000 Units) Forecast, by Application 2018 & 2031
- Table 15: South India India Women’s Health Therapeutics Market Revenue (USD billion) Forecast, by Application 2018 & 2031
- Table 16: South India India Women’s Health Therapeutics Market Volume (1,000 Units) Forecast, by Application 2018 & 2031
- Table 17: East India India Women’s Health Therapeutics Market Revenue (USD billion) Forecast, by Application 2018 & 2031
- Table 18: East India India Women’s Health Therapeutics Market Volume (1,000 Units) Forecast, by Application 2018 & 2031
- Table 19: West India India Women’s Health Therapeutics Market Revenue (USD billion) Forecast, by Application 2018 & 2031
- Table 20: West India India Women’s Health Therapeutics Market Volume (1,000 Units) Forecast, by Application 2018 & 2031
- Table 21: India Women’s Health Therapeutics Market Revenue USD billion Forecast, by Application 2018 & 2031
- Table 22: India Women’s Health Therapeutics Market Volume 1,000 Units Forecast, by Application 2018 & 2031
- Table 23: India Women’s Health Therapeutics Market Revenue USD billion Forecast, by Country 2018 & 2031
- Table 24: India Women’s Health Therapeutics Market Volume 1,000 Units Forecast, by Country 2018 & 2031
| Aspects | Details |
|---|---|
| Study Period | 2018-2032 |
| Base Year | 2023 |
| Estimated Year | 2024 |
| Forecast Period | 2024-2032 |
| Historical Period | 2018-2023 |
| Growth Rate | CAGR of 17.5% from 2018-2032 |
| Segmentation |
|
STEP 1 - Identification of Relevant Samples Size from Population Database
STEP 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segemnts, product and application.
Note* : In applicable scenarios
STEP 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
STEP 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
Additionally after gathering mix and scattered data from wide range of sources, data is triangull- ated and correlated to come up with estimated figures which are further validated through primary mediums, or industry experts, opinion leader.
About Market Research Forecast
MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.
Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.
